Agilent breaks ground on manufacturing expansion in Colorado 20-Feb-2023 By Rachel Arthur Agilent Technologies is making a $725m investment to double manufacturing capacity of therapeutic nucleic acids in Frederick, Colorado.
AGC Biologics acquires Colorado CGT facility 09-Aug-2021 By Rachel Arthur CDMO AGC Biologics has acquired a commercial manufacturing facility in Longmont, Colorado: giving it significant additional capacity and space to expand its global end-to-end cell and gene therapy offering.
AGC Biologics acquires commercial-scale facility from AstraZeneca 09-Jun-2020 By Ben Hargreaves The Colorado site currently possesses two 20,000L bioreactors, with the potential to add four more.
AZ to close two facilities in Colorado 15-Jan-2019 By Ben Hargreaves The UK company will close two facilities in Boulder and Longmont eliminating 210 positions.
